TTNP Stock DD Titan Pharmaceuticals, Inc. 08/08/2014 06:09:57

Message Board

Previous

| Next

Post# of 250682

Posted On: 08/08/2014 7:09:57 AM

Posted By: Rosner

TTNP Titan Pharmaceuticals, Inc. $TTNP Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=TTNP&...mp;yt0=Go!

Last Updated: 08/08/2014 06:09:52

Current Price and Quotes
Last Price 0.75
Previous Close 0.765 Open 0.75
Daily Range N/A - 0.7575 52wk Range 0.53 - 1.27
Volume 53,401 Dividend N/A
Average Vol (3m) 144,748 Yield N/A

Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 10,481 7,117 4,068 10,093
Cost of Revenue - - - -
Gross Profit 10,481 7,117 4,068 10,093
Operating Expenses

Research and Development 8,309 10,610 11,206 12,855
Sales, General and Admin. 3,063 4,877 3,368 3,263
Non-Recurring Items - - - -
Other - - - -
Operating Income (891) (8,370) (10,506) (6,025)
Income From Continuing Operations

Add'l Income/Expense Items 12,170 (1,949) 1,733 (131)
Earnings Before Interest and Tax 11,279 (10,319) (8,773) (6,156)
Interest Expense 1,568 4,861 6,430 678
Earnings Before Tax 9,711 (15,180) (15,203) (6,834)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 9,711 (15,180) (15,203) (6,834)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 9,711 (15,180) (15,203) (6,834)
Preferred Stock and Other Adjustments - - - 1,241
Net Income Applicable to Common Shareholders 9,711 (15,180) (15,203) (5,593)

Recent News

Aug 7, 2014 Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2014 Financial Results
Jul 21, 2014 Titan Pharmaceuticals Announces First Patient Enrollment in Clinical Study of Probuphine for Opioid Dependence
Jun 9, 2014 Titan Pharmaceuticals Receives Notice of Allowance for Patent of Implantable Polymeric Device for Sustained Release of Dopamine Agonists
May 14, 2014 Titan Pharmaceuticals Announces First Quarter 2014 Financial Results

(0)

(0)